Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IFA SENSIBAC NORFLOXACIN

K-Number: K892728 · 1989-09-21

ApplicantInvestigacion Farmaceutica S.A. DE C.V.
Decision Date1989-09-21
Product CodeJTN
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

IFA SENSIBAC NORFLOXACIN is the device name listed in this FDA 510(k) record. The listed applicant is Investigacion Farmaceutica S.A. DE C.V.. It received FDA 510(k) clearance on 1989-09-21 under 510(k) number K892728. The device is classified under product code JTN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IFA SENSIBAC NORFLOXACIN?

IFA SENSIBAC NORFLOXACIN is a medical device that received FDA 510(k) clearance on 1989-09-21. The listed applicant is Investigacion Farmaceutica S.A. DE C.V.. The 510(k) number is K892728.

When did IFA SENSIBAC NORFLOXACIN receive FDA 510(k) clearance?

IFA SENSIBAC NORFLOXACIN received FDA 510(k) clearance on 1989-09-21, under 510(k) number K892728.

Who is the listed applicant for IFA SENSIBAC NORFLOXACIN?

The FDA 510(k) record lists Investigacion Farmaceutica S.A. DE C.V. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IFA SENSIBAC NORFLOXACIN?

The FDA product code for IFA SENSIBAC NORFLOXACIN is JTN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Investigacion Farmaceutica S.A. DE C.V. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K892721IFA SENSIBAC CEFACLORK892735IFA SENSIBAC CEPHALOTINK892733IFA SENSIBAC KANAMYCINK892713IFA SENSIBAC NALIDIXIC ACIDK885110PROTEUS OX-19 IFA*K885113IFA* POSITIVE AND NEGATIVE ANTIGENS CONTROL

View all 24 devices →

Related Devices (Code: JTN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262113HardyDisk AST Tebipenem 10µg (TBP10)Hardy DiagnosticsK261781Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60Thermo Fisher Scientific (Oxoid Ltd.)K261853Gepotidacin GEP 10 µgLiofilchem, Inc.K260842HardyDisk AST Gepotidacin 10µg (GEP10)Hardy DiagnosticsK251337Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10Thermo Fisher Scientific (Oxoid Ltd.)K253105HardyDisk AST Cefiderocol 30µg (FDC30)Hardy Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑